ea0022p618 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010
Reimondo Giuseppe
, Palmas Enrico
, Vannelli Silvia
, Bellone Jaele
, Bellone Simonetta
, Matarazzo Patrizia
, Gasco Valentina
, Borraccino Alberto
, Migliaretti Giuseppe
, Cavallo Franco
, Ravaglia Aldo
, Angeli Alberto
, Aimaretti Gianluca
, Terzolo Massimo
The potential side effects of the rhGH therapy have been evaluated only during treatment and the accessible databases have been developed as a post-marketing surveillance only by the Companies distributing rhGH. Aim of the present study was to evaluate health consequences (metabolic diseases and/or malignancies) in adults previously treated with rhGH during childhood. We recruited 284 patients (median age at diagnosis 12 years, range 317) who underwent rhGH treatment bet...